William Blair analyst Andrew Nicholas has maintained their bullish stance on HURN stock, giving a Buy rating on April 28.
Andrew Nicholas has given his Buy rating due to a combination of factors including Huron Consulting’s strong first-quarter performance and positive future outlook. The company’s net revenue exceeded expectations, driven by significant growth in its healthcare and commercial segments. Additionally, the adjusted earnings per share surpassed both the firm’s and consensus estimates, largely due to a favorable tax rate.
Huron’s business pipeline remains robust and is expanding across all segments, with a notable increase in sales conversion compared to the previous year. Management has not observed any decline in project work due to regulatory changes, and the company continues to adapt its services to meet evolving client needs. The reaffirmation of the 2025 guidance, which anticipates substantial revenue growth and strong adjusted EBITDA margins, further supports the Buy rating, as it reflects confidence in the company’s ability to navigate external challenges and capitalize on opportunities.
In another report released on April 28, Benchmark Co. also reiterated a Buy rating on the stock with a $165.00 price target.
Based on the recent corporate insider activity of 66 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of HURN in relation to earlier this year.